Organizational Readiness

This technical assistance brief will review many aspects of crisis system collaboration, incorporating stakeholder input gathered during this exciting transition from a default emergency medical and law enforcement response to a more intentional, varied continuum of behavioral health crisis responses.

This paper focuses on the potential that technological innovations have in making behavioral health crisis services more accessible and equitable across the United States and includes case studies from states and providers who were early adopters of leveraging technology to facilitate crisis care.

This paper outlines many important considerations in delivering medical psychiatric crisis care and provides information and recommendations to improve practices and ultimately better meet the needs of individuals served.

This paper discusses employee- and organization-level strategies to combat barriers to employee recruitment, retention, and wellness among the crisis response and general behavioral health workforce.

This technical assistance brief reviews areas of critical need in mental health services across the United States. It discusses the behavioral health workforce, youth mental wellness, the justice system, social determinants of health, suicide, and drug-related overdose fatalities. It highlights five core principles that guide strategies to combat these problems.

The document reviews billing codes for integrated behavioral health care, including substance use services.

The article reviews misinformation surrounding the opioid crisis and presents five facts that help to debunk these myths.

This advisory highlights the need for primary substance use prevention programs for young adults ages 18 to 25 with disabilities, provides guidance to prevention specialists on designing and tailoring these programs, and describes factors that may affect the delivery of prevention.

This one-hour, on-demand, journal article-based activity explores patterns of xylazine use among people who inject drugs, and considers its implications for public health.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses how to identify and treat xylazine-associated wounds with patient-centered strategies.This didactic case-based session addresses national xylazine trends, drug properties, overdose and withdrawal management, wound care, pain management, and harm reduction with a focus on patient-centered care.